Plain-English translation of NCT06994650 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called to see if it can help people who have obstructive sleep apnea (a condition where breathing stops and starts during sleep) and obesity. Participants in this trial are people who are already using a positive airway pressure machine (PAP therapy) to help them breathe at night. The researchers want to learn whether this medication, given as an injection, is safe and effective at improving symptoms when used alongside the breathing machine.
People with both sleep apnea and obesity often struggle to lose weight and manage their condition with current treatments alone. This trial exists to see whether this medication might offer an additional treatment option to help these patients improve their health.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive either the new medication () or a placebo (inactive treatment) by injection. You'll need to visit the clinic multiple times for check-ups and sleep studies. Importantly, you'll be asked to pause your PAP breathing machine for at least one week before each sleep study so the doctors can measure how the medication is working. The trial will carefully monitor your safety and track whether the treatment helps reduce your sleep apnea symptoms and supports weight management.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China